Human rhinoviruses (HRV) are a major cause of asthma exacerbations and hospitalization. Studies using primary cultures suggest that this may be due to impaired production of type I and type III IFNs by asthmatic bronchial epithelial cells. Although epithelial cells are the main target for HRV infection, HRV can be detected in the subepithelial layer of bronchial mucosa from infected subjects by in situ hybridization. Therefore, we postulated that submucosal fibroblasts are also involved in the innate antiviral response to HRV infection in asthma. We found that regardless of subject group, bronchial fibroblasts were highly susceptible to RV1b infection. IL-8 and IL-6 were rapidly induced by either HRV or UV-irradiated virus, suggesting that these responses did not require viral replication. In contrast, RANTES expression was dependent on viral replication. Regardless of disease status, fibroblasts did not respond to HRV infection with significant induction of IFN-␤, even though both groups responded to synthetic dsRNA with similar levels of IFN-␤ expression. Exogenous IFN-␤ was highly protective against viral replication. Our data suggest that fibroblasts respond to HRV with a vigorous proinflammatory response but minimal IFN-␤ expression. Their susceptibility to infection may cause them to be a reservoir for HRV replication in the lower airways, especially in asthmatic subjects where there is reduced protection offered by epithelialderived IFNs. Their ability to support viral replication coupled with their vigorous proinflammatory response following infection may contribute to asthma exacerbations.
H uman rhinoviruses (HRV)
3 are a major of cause of asthma exacerbations in children and adults (1, 2) . These exacerbations are normally associated with increased airway hyperresponsiveness and leukocyte influx into the lungs (3) . HRV targets the bronchial epithelium, where its replication can eventually lead to cytopathic cell death and the release of infectious virions. In response to infection, epithelial cells initiate an innate immune response characterized by the expression of proinflammatory mediators and the induction of antiviral proteins. The proinflammatory response is typified by the production of an array of chemokines and cytokines, including IP-10 (CXCL10), RANTES (CCL-5), IL-6, and IL-8 (4) . The antiviral response is critically dependent on the production of type I and type III IFNs, such as IFN-␤ and the IFN-s (IL-28/29), respectively (5) . Signaling via the type I IFN receptor induces a rapid response, including activation of the apoptotic machinery leading to early apoptosis of infected cells, preventing viral replication and promoting efficient phagocytosis of infected cells. In our previous studies, we showed that bronchial epithelial cells (BECs) from asthmatic donors exhibited increased susceptibility to HRV infection accompanied by defective IFN-␤ (6) and IFN-(7) responses. These studies provide, for the first time, a plausible explanation for the tendency of asthmatic subjects to have lingering lower respiratory tract problems as a consequence of rhinovirus (RV) infection.
Although epithelial cells are the main target for HRV infection, several studies have indicated that HRV may be detected in the subepithelial layer by in situ hybridization (8, 9) and that human lung fibroblasts are susceptible to HRV infection (10) . Bronchial fibroblasts are part of the mesenchymal layer in the airway tissue and have the versatility to differentiate into other connective tissue families such as smooth muscle cells and myofibroblasts (11) . They are an important component of the epithelial mesenchymal trophic unit, forming an attenuated fibroblast sheath lying just beneath the epithelium (12) . This organization allows the fibroblasts to respond in a local manner to infectious agents, tissue injury, or other environmental factors as they impinge on the epithelium and to mediate the response of other tissues to these stimuli. Thus, fibroblasts play a key role in maintaining tissue homeostasis and may also have the potential to contribute to disease pathogenesis through their contribution to inflammatory and remodeling responses (11, 13) .
In the current study, we characterized the response of normal and asthmatic airway fibroblasts to RV1b infection in vitro and found that viral inocula as low as 0.01 multiplicity of infection (MOI) caused pronounced cytopathic effects. In response to infection, mRNA induction of IL-8, IL-6, and TNF-␣ was rapid but transient, whereas RANTES gene expression was more sustained. We did not detect any significant expression of IFN-␤ during the early stages of RV1b infection, and fibroblasts showed no significant disease-related differences in their cellular responses or virus susceptibility. In contrast, synthetic dsRNA was able to induce IFN-␤ expression, although the sensitivity was reduced in comparison with proinflammatory cytokine responses. Finally, exogenous IFN-␤ exerted significant protective effects against viral infection, suggesting that paracrine signaling from neighboring epithelial cells may be required for stromal protection.
Materials and Methods

Culture of primary bronchial fibroblasts and exposure to RV
Primary fibroblasts were grown from bronchial biopsies obtained from normal (n ϭ 10) and asthmatic donors (n ϭ 10) by fiberoptic bronchoscopy and were cultured as previously described (14) . The normal subjects (7:3 male/female; mean age 25.7, range 20 -38 years) had a mean Ϯ SD forced expiratory volume in 1 s (FEV 1 ) of 103 Ϯ 11% predicted and a provocative concentration of methacholine causing a 20% fall in FEV 1 (PC 20 ) of Ͼ16 mg/ml; the asthmatic subjects (6:4 male/female; mean age 32, range 18 -59 years) had an FEV 1 of 97 Ϯ 18% predicted and a PC 20 (geometric mean) of 3.3 mg/ml (based on 9/10 subjects). All subjects had been free of any respiratory infection for 8 wk before bronchoscopy. For disease control, asthmatic volunteers received either ␤ agonists or inhaled corticosteroids alone or in combination. Complete details of the patient information are provided in supplemental Table I in Extended Methods online. 4 The fibroblasts were kindly provided by Dr. S. Puddicombe (Synairgen Research) and were routinely tested and found free from mycoplasma infection.
Rhinovirus-1b (RV1b) stocks and viral titers were determined in HeLa cell titration assays, as previously described (15) . UV-inactivated RV1b was used to show the requirement for viral replication. Fibroblasts were infected at 90% confluence. Cells were infected with RV1b at MOI ϭ 0.01-0.08 for 1 h at room temperature with shaking. The virus was then removed and the cells were washed and incubated in fresh medium for the appropriate times at 37°C. Where appropriate, the PI3K inhibitor LY294002 (Calbiochem) was added 1 h before infection. Synthetic dsRNA (polyinosinic-polycytidylic acid (poly(I:C); Autogen Bioclear) was diluted in cell culture medium.
Lactate dehydrogenase (LDH) assays
LDH was measured using CytoTox 96 nonradioactive cytotoxicity assay (Promega) according to the manufacturer's instructions.
IL-8 ELISA
IL-8 release was analyzed by ELISA (human IL-8 CytoSet kit; Biosource International) according to the manufacturer's instructions.
IFN-␤ ELISA
IFN-␤ release was analyzed by ELISA (human IFN-␤ ELISA kit; PBL InterferonSource) according to the manufacturer's instruction. Samples from fibroblast cultures were concentrated using Microcon YM-10 filter units (Millipore) acco*rding to the manufacturer's instructions. Samples from epithelial cell cultures were analyzed without concentrating.
RNA extraction and real-time quantitative PCR analysis
RNA was extracted using TRIzol reagent (Invitrogen), DNase treated, and reverse-transcribed for quantitative PCR (qPCR) as previously described (16) . Genes of interest were normalized to the geometric means of ubiquitin C and phospholipase A2. The primer sequences used for each target gene are provided in the online repository.
Statistical analysis
Within group comparisons were performed using Wilcoxon signed-rank test and between group comparisons were performed using the MannWhitney U test. Values of p Ͻ 0.05 were considered significant; where statistical significance was observed, p values are displayed.
Results
Characterization of the responses of primary bronchial fibroblasts to RV infection
To optimize the model for infection of primary bronchial fibroblasts with RV1b, fibroblasts from one normal donor were infected with increasing amounts of RV1b in vitro. Using phase-contrast microscopy, we observed a dose-dependent cytopathic effect (CPE) due to RV1b replication. Infection using MOI values of 0.01-0.08 (1-8 infectious particles per 100 cells) caused a low level of CPE at 9 h following the first round of viral replication, reflecting the expected level of infection. This increased at 24 and 48 h. No virus-dependent CPE was observed when cells were incubated with UV-irradiated virus. (Fig. 1) . Infection also elicited a time-and dose-dependent increase in IL-8 production ( Fig. 2A) . In contrast with our previous observations of airway epithelial cells (6), a significant increase in IL-8 production was observed even in the fibroblast cultures exposed to UV-irradiated RV1b, which was used to assess the dependency of the response on viral replication.
The cytopathic effect of RV1b was assessed by measuring cytosolic LDH release into the culture supernatant. At 24 h postinfection (p.i.), Ͻ10% cell death was observed in RV1b -infected cells (Fig. 2B) . However, at 48 h p.i. a dose-dependent increase in cell death was observed with Ͼ40% cell death at the highest dose of RV1b. The amount of cell death seen with UVirradiated virus was comparable to that to control samples (Fig.  2B ). The increase in cytopathic cell death caused by RV1b was associated with a time-and dose-dependent increase in the release of infectious virus particles; no infectious viral particles were produced from cells incubated with UV-irradiated virus ( 
Normal and asthmatic primary bronchial fibroblasts respond to RV1b infection with an immediate proinflammatory response
In view of the sensitivity of the fibroblasts to RV1b infection, we performed subsequent experiments using an MOI of 0.05 to profile gene expression occurring as an immediate response to RV1b infection without the complications of CPE and secondary infection. Therefore, cultures from 10 normal and 10 asthmatic donors were infected with RV1b and harvested at 2-8 h p.i. RV1b transcripts were detectable as early as 2 h p.i. and increased over 8 h p.i. No transcripts were detected with UV-irradiated RV1b. No statistical difference in viral replication was observed between normal and asthmatic groups (Fig. 3) .
To assess proinflammatory mediator production, expressions of IL-6, IL-8, TNF-␣, and RANTES mRNA were quantified by RTqPCR. IL-6 and IL-8 were significantly induced by RV1b in both normal and asthmatic fibroblasts at 2 h p.i. (Fig. 4 , A and B) but 4 The online version of this article contains supplemental material.
FIGURE 1.
Characterization of the responses of primary bronchial fibroblasts to RV infection. To optimize the model for infection of primary bronchial fibroblasts with RV1b, fibroblasts from one normal donor were infected with increasing amounts of RV1b. Using phase-contrast microscopy at 24 h, we observed a dose-dependent CPE (rounded cells) due to RV1b replication. No virus-dependent CPE was observed when cells were incubated with UV-irradiated virus.
had returned to baseline levels by 8 h p.i. Similar transient kinetics were observed for TNF-␣ gene expression (supplemental data available online in Extended Methods). At 24 h, IL-6 and IL-8 proteins were also significantly elevated in cultures of asthmatic fibroblasts infected with RV1b; normal fibroblasts responded similarly, except that the induction of IL-8 failed to achieve statistical significance (Fig. 4, C and D) . There was no significant diseaserelated difference between the proinflammatory responses of the fibroblasts to RV1b. As found in the initial dose-finding studies, IL-8 as well as IL-6 mRNA expression was significantly induced in cells incubated with UV-irradiated virus. However, at the protein level this only reached statistical significance in the case of IL-6 release from asthmatic fibroblasts.
Previous studies have shown that IL-8 gene expression in BECs infected with RV-39 is independent of viral replication, being triggered by viral endocytosis and activation of PI3K (17) . Pretreatment of bronchial fibroblasts with the PI3k inhibitor LY294002 for 1 h before infection inhibited expression of IL-8 or IL-6 induced by either RV1b or UV-irradiated RV1b (Table I ). In these experiments, LY294002 dose-dependently blocked the induction of IL-8 mRNA in response to UV-irradiated RV1b but was less potent against RV1b induced IL-6 expression. These data suggest that at least a proportion of the proinflammatory response is due to mechanisms linked to viral endocytosis and is independent of viral replication.
In contrast with the induction of IL-6 and IL-8 mRNA, RANTES expression was dependent on viral replication, because no induction was seen with UV-irradiated virus (Fig. 5A) . Induction of RANTES mRNA also showed a different kinetic profile as that seen with IL-6, IL-8, and TNF-␣. In this case, induction was significant at 4 h p.i. in both normal ( p ϭ 0.012) and asthmatic ( p ϭ 0.029) fibroblasts (Fig. 5A ) and was sustained up to 8 h p.i. There was no significant difference between normal and asthmatic fibroblasts in the mRNA expression of this cytokine. Even though RANTES mRNA had been induced, we could not detect significant levels of RANTES protein in either healthy or asthmatic fibroblasts infected in RV, suggesting that although there was detection of dsRNA leading to increased gene transcription, this did not lead to accumulation of the RANTES protein.
IFN-␤ was not significantly induced by RV1b in fibroblasts but was rapidly induced by treatment with dsRNA
Even though viral RNA (vRNA) was detectable in the infected cultures and the expression of RANTES had been triggered in a replication-dependent manner, we found no significant induction of IFN-␤ transcription after RV1b infection (Fig. 5B) . Although a few subjects in the normal control group showed some IFN-␤ expression at 8 h, we were unable to detect IFN-␤ protein in any fibroblast cultures at 24 h p.i.(n ϭ 9 normals; n ϭ 5 asthmatics); in these experiments, parallel infection of two BEC cultures with RV1b at the same MOI (0.05) yielded detectable IFN-␤ (2.49 and 2.2 ng/ml) 24 h p.i.
As we were unable to detect induction of IFN-␤ in response to RV infection, we treated fibroblasts with synthetic dsRNA (poly(I: C)), a TLR3 agonist, which allowed us to measure the induction of IFN-␤ mRNA in the absence of cytopathic cell death. This agonist caused high and sustained levels of RANTES and IL-8 expression (Fig. 6A) . IFN-␤ mRNA was also rapidly induced during the first 2 h of exposure but decayed 8 h posttreatment (Fig. 6B) . Interestingly, the induction of IL-8 and RANTES was maximal at Յ10 g/ml poly(I:C), whereas the IFN-␤ response continued to rise at all doses tested. Thus, it appeared that the sensitivity of the type I IFN response was lower than that of the proinflammatory response, consistent with that observed in response to RV infection.
Because poly(I:C) stimulation led to the induction of IFN-␤ expression, we compared the responses of normal and asthmatic fibroblasts in this model. We examined both the kinetics and dose response for the induction of IFN-␤ by using fibroblasts from six normal and six asthmatic volunteers to ensure that any differences in sensitivity or magnitude of response were uncovered. IFN-␤ mRNA was induced in a dose-dependent manner in normal and asthmatic fibroblasts; however, no significant differences between the groups at 2, 4, 8, and 24 h were observed at all concentrations FIGURE 4. Induction of proinflammatory genes in response to RV1b infection. Fibroblasts were treated as in Fig. 3 and RT-qPCR and ELISA were used to measure mRNA expression (2 h p.i.) and protein release (24 h p.i.), respectively, of IL-6 (A and C) and IL-8 (B and D). mRNA expression data were analyzed and presented as in Fig. 3 . Fibroblasts from a normal donor were pretreated for 1 h with inhibitor followed by RV1b infection as described in Materials and Methods. Cells were harvested 2 h p.i. and analyzed for IL-8 and IL-6 mRNA expression. ND, Not done. ‫,ء‬ p Ͻ 0.05 versus RV1b or UV-irradiated (UVi) RV1b-treated controls; ‫,ءء‬ p Ͻ 0.01. of poly(I:C) tested (Fig. 6C) . We also measured IFN-␤ protein released from normal and asthmatic fibroblasts treated with 1 and 10 g/ml poly(I:C) but found no significant differences between the two groups (Fig. 6D) . As with IFN␤, we were also able to detect RANTES protein following stimulation with poly(I:C).
Exogenous IFN-␤ protects primary bronchial fibroblasts from RV1b infection
Given the lack of endogenous IFN-␤ production by bronchial fibroblasts during early stages of RV infection, we postulated that this may account for their high susceptibility to RV infection. Therefore, we pretreated fibroblasts with IFN-␤ for 24 h and subsequently infected them with RV1b (MOI ϭ 0.05) for 8 h. Phasecontrast pictures show clear CPE in cells infected with RV1b in the absence of IFN-␤; in contrast, no CPE was observed in RV1b-infected cells in the presence of IFN-␤ (Fig. 7A) . In parallel, RV1b vRNA was significantly reduced in the presence of IFN-␤ in the normal group ( p ϭ 0.028), as well as in the asthmatic group ( p ϭ 0.001) (Fig. 7B) . There was also a significant decrease in RV1b virus particles released into the culture medium in the presence of IFN-␤ ( p ϭ 0.002) (Fig. 7C) . Because RV1b induced proinflammatory cytokine production in the absence of replication, we also determined whether the presence of IFN-␤ had an impact on the production of IL-8. In these experiments, fibroblasts were pretreated with IFN-␤ for 24 h before being infected with RV1b. Expression of IL-8 mRNA was not significantly induced by IFN-␤ FIGURE 5. Induction of RANTES and IFN-␤ in response to RV1b infection. Fibroblasts were treated as in Fig. 3 and RT-qPCR used to measure mRNA expression of RANTES (A) and IFN-␤ (B) at 4 h p.i. Data were analyzed and are presented as in Fig. 3.   FIGURE 6 . Kinetics and dose responses to poly(I:C). Fibroblasts were exposed to poly(I:C) for up to 24 h. Total RNA was extracted and RT-qPCR was used to measure the expression of RANTES and IFN-␤. Data were analyzed as in Fig. 2. A and B , The graphs show mean values for RANTES (A) and IFN-␤ (B) mRNA expression at 2 and 8 h posttreatment with poly(I:C); data were obtained in three independent experiments using fibroblasts of one normal subject. C, Plot shows median values for IFN-␤ mRNA expression by fibroblasts from six normal (F) and six asthmatic (f) subjects 2 h posttreatment with poly(I:C). D, The box plots show data for IFN-␤ protein release from six normal and six asthmatic fibroblasts measured 24 h postexposure to 1 or 10 g/ml poly(I:C). The limit of detection was 25 pg/ml. The three data points marked with an asterisk were below the limit of detection and were given a value of 25 pg/ml for analysis. Data were analyzed using the Kruskal-Wallis test or the Mann-Whitney U test. treatment alone but was significantly increased at 8 h p.i. with RV1b (i.e., after 32 h of IFN-␤ treatment) in cultures of normal (but not asthmatic) fibroblasts (Fig. 7D) . However, IFN-␤ pretreatment did not augment IL-8 production in response to RV1b infection (Fig. 7E) .
Discussion
Our studies have demonstrated that infection of primary bronchial fibroblasts with RV1b in vitro induced a rapid proinflammatory response in the absence of any significant induction of IFN-␤. Consequently, the cells were permissive for viral replication and were highly susceptible to virus-induced CPE, which we have shown could be prevented by treatment with exogenous IFN-␤. Although the fibroblasts failed to make IFN-␤ in response to RV1b, treatment with synthetic dsRNA induced a rapid IFN-␤ response, demonstrating their capability to make IFN-␤ in the presence of a danger signal. However, we did not observe any difference in the ability of normal or asthmatic fibroblasts to make IFN␤ mRNA in response to poly(I:C). These findings do not support the hypothesis that the defective innate immune response previously reported in asthmatic bronchial epithelial cells (6) is mirrored in other structural cells from the asthmatic airway as a consequence of a common underlying genetic mechanism.
The susceptibility of bronchial fibroblasts to RV1b was striking. RV1b-specific vRNA was demonstrable as early as 2 h p.i. with RV1b (MOI ϭ 0.05) and was dependent on viral replication, as no readout was detectable in cells incubated with UV-irradiated virus. Although there was a trend for higher viral replication in the asthmatic fibroblasts at 4 h, which may have reached statistical significance if more fibroblasts were tested, it is unlikely that this small relative difference would have much biological relevance because it is clear that the normal fibroblasts were also highly susceptible to infection by RV1B at the later time point. Infection caused a low level of CPE at 9 h following the first round of viral replication, reflecting the expected level of infection. Following subsequent rounds of viral replication, CPE increased at 24 and 48 h with large-scale cell death being evident. Our findings are consistent with the fact that diploid fibroblast cell lines are used for propagation of HRV and are more efficient than HeLa cells for recovery of HRVs from clinical isolates (18) , further underlining their permissiveness for RV replication. However, our results contrast with a previous study in which lung fibroblasts were infected with RV at an MOI of 10, yet infection of only 5-15% of cells was observed (10) . In a small study comparing fibroblasts from two normal and two asthmatic donors, we also observed that higher doses of RV16 were required for infection. However, we still failed to see a significant induction of IFN␤ by either group of fibroblasts. As RV16 is a major group virus that uses ICAM-1 to infect cells whereas RV1b is a minor group virus that uses the low-density lipoprotein receptor for entry, the observed difference in susceptibility may reflect differences in receptor levels. However, as ICAM1 is up-regulated by proinflammatory cytokines such as TNF-␣ (19), it would be of interest to evaluate the susceptibility of primary fibroblasts to RV16 infection after treatment with TNF-␣ to up-regulate ICAM-1 expression.
In view of their susceptibility to the cytopathic effects of RV1b, we examined the kinetics of the fibroblast responses at early time points (0 -8 h p.i.) to determine the primary responses to viral infection before significant cell death occurred. Messenger RNA expression of the proinflammatory cytokines IL-8, IL-6, and TNF-␣ was rapidly induced by RV1b infection, but no diseaserelated differences were observed, similar to our findings with primary BECs (4, 6) . We also found no significant differences in RV-1b-induced IL-8 and IL-6 protein release. These data contrast with the findings of Oliver et al., who found that human airway smooth muscle (HASM) cells from asthmatic subjects have significantly increased IL-6 and IL-8 production in response to RV infection, which was attributed to differences in transcriptional regulation of the cytokines (20) . This difference between fibroblast and HASM cells may reflect cell-type specific responses.
In contrast with our previous studies in BECs, where proinflammatory cytokine gene expression was dependent on viral replication (4, 6), we observed induction of IL-6 and IL-8 by bronchial fibroblasts in the presence of UV-irradiated virus. This indicates that the mechanisms of signal transduction leading to cytokine production can differ depending on cell type. However, in their studies of HASM cells, Oliver et al. also reported that IL-6 and IL-8 release was induced by both RV16 and UV-irradiated RV16 (20) , which is consistent with our findings. This suggests that, in mesenchymal cells, at least a part of the expression of IL-6 and IL-8 occurs independently of viral replication. It seems highly unlikely that this response is due to the presence of endotoxin, as the medium we used was endotoxin-free and we had no evidence of bacterial infection in any of our cultures. It is most likely that the fibroblasts are responding to cytokines or damage-associated molecular patterns released by the HeLa cells during propagation of the virus. In related studies, we have found that conditioned medium from RV-infected bronchial epithelial cells elicits a marked proinflammatory response when applied to bronchial fibroblasts (21) .
Previous studies have shown that RV-39 (a major group virus)-induced IL-8 expression in epithelial cells occurred by ICAM binding and activation of PI3K (17, 22) . In our studies, we also found that inhibition of PI3K down-regulated both IL-8 and IL-6 mRNA induced by RV1b. This suggests that a minor group virus also activates PI3K and therefore that the activation of PI3K is not directly dependent on ICAM binding. Other studies have also suggested that IL-8 release from virally infected fibroblasts involves the stimulation of reactive oxygen species at the cell surface via a flavoprotein that may act in concert with p47 phox (23) . This pathway may control residual IL-8 and IL-6 expression in our model.
Although we observed increases in fibroblast RANTES mRNA expression 4 -8 h p.i., indicating their ability to sense active viral replication, there was no significant induction of IFN-␤ expression in response to viral infection up to 8 h p.i. This suggests that the signals leading to RANTES and IFN-␤ expression are distinct. Such a proposal would also explain why induction of RANTES and IFN-␤ by the synthetic dsRNA poly(I:C) showed a different dose response (Fig. 6 ). Several mechanisms have been identified for detection of dsRNA, including TLR3, RIG-I (retinoic acidinducible gene I), and MDA-5 (melanoma differentiation-associated gene 5), all of which lead to activation of IRF-3 (IFN response factor 3), as well as dsRNA-dependent protein kinase, PKR, which uses NFB for control of transcription (24) . Studies using BECs have suggested that RANTES expression is mediated by PKR (25) , although the detection of dsRNA by host cells is known to occur in a cell type-and pathogen type-specific manner. A recent study by Kotla et al. (26) has reported a deficient IFN-␤ response to RV14 infection in a lung alveolar epithelial cell line, which was shown to be due to a lack of IRF-3 activation following RV14 infection. In these studies, inhibition of viral protein synthesis resulted in an increase in IFN-␤ mRNA levels, suggesting that a virally encoded factor prevented activation of the type I IFN response. Whether a similar anti-IFN mechanism can be used by RV1b in fibroblasts remains to be determined.
Even though we did not observe significant induction of IFN-␤ mRNA in bronchial fibroblasts in response to RV1b, we were able to elicit expression using ds RNA. This difference may be due to the cellular location of TLR-3, a key sensor of dsRNA that controls IFN-␤ expression (24) . Although TLR-3 is predominantly localized in endosomes in epithelial cells (27) , it has been found on the surface of fibroblasts (28) . Extracellular localization of TLR3 could explain the slow kinetics of IFN-␤ expression in response to RV, as activation would be dependent on the detection of dsRNA released by the lysis of infected cells. It may also account for the occasional detection of IFN-␤ mRNA in normal fibroblast cultures 8 h p.i. However, we failed to detect significant IFN-␤ protein at 24 h, suggesting that insufficient induction of IFN-␤ mRNA expression had occurred to result in an increase in protein synthesis. In vivo, localization of TLR-3 on the surface of fibroblasts would allow them to detect extracellular dsRNA released from infected epithelial cells and, as a consequence, serve as sensors of infection in the epithelial-mesenchymal trophic unit, propagating and amplifying signals to the immune system (29) .
The high susceptibility of fibroblasts to RV infection has potential implications for asthma exacerbations. In asthmatic airways, it is known that the bronchial epithelium is damaged (30) and that epithelial shedding occurs (31) . This may increase the probability that the underlying fibroblasts are accessible to RV during an infection. The poor ability of fibroblasts to mount their own innate immune response implies that local IFN production is essential for triggering an antiviral response in these cells. However, we have already demonstrated that asthmatic BECs have a deficient innate immune response (6, 7) , compromising the local immune response in the airway microenvironment. The lack of an antiviral response, but the clear presence of a proinflammatory response, suggest that airway fibroblasts may contribute to inflammation and asthma exacerbation (Fig. 8) . Our demonstration that exogenous IFN-␤ FIGURE 8. Model for the contribution of bronchial fibroblasts to inflammation during a viral-induced asthma exacerbation. Airway fibroblasts may be susceptible to infection in asthma due to an epithelial disruption that facilitates entry of the virus to the submucosa. Once infected, the lack of an antiviral IFN-␤ response by the fibroblasts coupled with a deficient protective epithelial innate immune response in asthma renders the cells permissive for viral replication, leading to prolonged infection. However, the ability of the fibroblasts to respond to RV with a proinflammatory response compounds the existing airway inflammation to contribute to an exacerbation.
protects fibroblasts against infection adds weight to the argument that treatment with exogenous IFN-␤ is a potential therapy against virus-induced asthma exacerbations.
